How is the Monopar Therapeutics Inc today?

The Monopar Therapeutics Inc today is trading in the down by -5.42% at 30.01.

What is Monopar Therapeutics Inc Annual Net Profit?

Monopar Therapeutics Inc Annual Net Profit fell 85.5% in the last year to $15.59 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Monopar Therapeutics Inc Price to Earning Ratio?

Monopar Therapeutics Inc Price to Earning Ratio is -11.08, which is negative.

What is Monopar Therapeutics Inc Stock Price?

Monopar Therapeutics Inc Stock Price rose 880.72% and outperformed its sector by 842.13% in the past year.

What is Monopar Therapeutics Inc Quarterly Net profit?

Monopar Therapeutics Inc Quarterly Net profit fell 59.94% YoY to $2.62 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Monopar Therapeutics Inc Return on Equity(ROE)?

Monopar Therapeutics Inc Return on Equity(ROE) for the last financial year was -51.42%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Monopar Therapeutics Inc Mutual Fund Holding?

Monopar Therapeutics Inc Mutual Fund Holding increased by 0.27% in the last quarter to 2.61.

What is Monopar Therapeutics Inc Promoter Share Holding?

Monopar Therapeutics Inc Promoter Share Holding increased by 0.21% in the most recent quarter to 2.66%.

What is Monopar Therapeutics Inc Institutional Holding?

Monopar Therapeutics Inc Institutional Holding increased by 3.7% in the last quarter to 47.09.

Monopar Therapeutics Inc XNAS: MNPR

Monopar Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Monopar Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Monopar Therapeutics Inc
Rating: 1.27583325
Author: Trendlyne DVM scores

about

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prev...

30.01 -1.72 (-5.42%)

44.53% Fall from 52W High

66,548 XNAS Volume

High volume+loss today

XNAS 02 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

5.8 / 100

Technically Neutral

45.2 / 100

No estimates available

Monopar Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Monopar Therapeutics Inc FAQ

How is Monopar Therapeutics Inc today?

Monopar Therapeutics Inc today is trading in the red, and is down by -5.42% at 30.01.

How has Monopar Therapeutics Inc performed historically?

Monopar Therapeutics Inc is currently trading down -5.42% on an intraday basis. In the past week the stock fell -15.35%. stock has been down -14.53% in the past quarter and rose 880.72% in the past year. You can view this in the overview section.